A股異動 | 樂歌股份(300729.SZ)漲停 預計上半年淨利潤同比增長155.5%-185.3%
格隆匯6月15日丨樂歌股份(300729.SZ)漲停,封單逾7萬手,現報34.83元,暫成交249萬元,最新總市值30億元。樂歌股份昨日公佈,預計2020年半年度歸屬於上市公司股東的淨利潤6000萬元-6700萬元,同比增長155.5%-185.3%。報告期收入比去年同期增長35%左右,其中二季度同比增長60%左右。此外,期內公司人體工學工作站系列產品銷售大幅增長,尤其線性驅動系列產品銷售同比增長150%左右,其中,預計二季度線性驅動系列產品銷售同比增長215%左右;境外電商銷售同比增長68%左右。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.